Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals - Top-Institutions - MDSpire

Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals

  • By

  • Julian P. Struck

  • Maike Schnoor

  • Andrea Schulze

  • Marie C. Hupe

  • Tomasz Ozimek

  • Immanuel A. Oppolzer

  • Marco J. Schnabel

  • Maximilian Burger

  • Christopher Darr

  • Viktor Gruenwald

  • Boris Hadaschik

  • Maximilian Weinke

  • Hubert Kuebler

  • Jonas C. Klockenbusch

  • Markus T. Grabbert

  • Christian Gratzke

  • Mario W. Kramer

  • Alexander Katalinic

  • Axel S. Merseburger

  • November 30, 2021

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Uro-Oncology
    • Medical Oncology
    • Infectious Diseases

  • #2

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Berlin

    Key Differentiators

    • Urology
    • Oncology
    • Infectious Diseases

  • #3

    University Hospital Munich (LMU Klinikum)
    University Hospital Munich (LMU Klinikum)

    Munich, Bavaria

    Key Differentiators

    • Uro-Oncology
    • Medical Oncology
    • Immunology

  • #4

    University Hospital Freiburg
    University Hospital Freiburg

    Freiburg, Baden-Württemberg

    Key Differentiators

    • Urology
    • Oncology
    • Public Health

  • #5

    University Hospital Hamburg-Eppendorf (UKE)
    University Hospital Hamburg-Eppendorf (UKE)

    Hamburg, Hamburg

    Key Differentiators

    • Urology
    • Oncology
    • Epidemiology

Original Source(s)

Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals

  • by Julian P. Struck, Maike Schnoor, Andrea Schulze, Marie C. Hupe, Tomasz Ozimek, Immanuel A. Oppolzer, Marco J. Schnabel, Maximilian Burger, Christopher Darr, Viktor Gruenwald, Boris Hadaschik, Maximilian Weinke, Hubert Kuebler, Jonas C. Klockenbusch, Markus T. Grabbert, Christian Gratzke, Mario W. Kramer, Alexander Katalinic, Axel S. Merseburger

  • November 30, 2021

Related Content

Temporal changes in the risk of six-month post-COVID symptoms: a national population-based cohort study

Correction: Neurological manifestations of SARS-CoV-2 infection: protocol for a sub-analysis of the COVID-19 critical care consortium observational study

COVID Vaccines: Ask The Experts with Dr. Anthony Fauci

Dr. Anthony Fauci and a panel of public health experts gathered live to discuss the COVID-19 pandemic in Florida and answer questions about the vaccines.

  • February 15, 2021

  • 1 min